The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer

Over 300,000 patients develop squamous cell carcinoma of the head and neck (HNSCC) worldwide with 25-30% of patients ultimately dying from their disease. Currently, molecular biomarkers are not used in HNSCC but several genes have been identified including mutant TP53 (mutp53) Our recent work has id...

Descripción completa

Detalles Bibliográficos
Autores principales: Coaxum, Sonya D., Tiedeken, Jessica, Garrett-Mayer, Elizabeth, Myers, Jeffrey, Rosenzweig, Steven A., Neskey, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410280/
https://www.ncbi.nlm.nih.gov/pubmed/28160562
http://dx.doi.org/10.18632/oncotarget.14967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410280/
https://www.ncbi.nlm.nih.gov/pubmed/28160562
http://dx.doi.org/10.18632/oncotarget.14967

Ejemplares similares